AGENUS INC (AGEN) earnings date
Mar 16, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 42 days, typically, give or take 15 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 5, 2026 | before open | 36 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | before open | 37 | 8-K |
| Q1 FY2026 | Mon, May 11, 2026 | before open | 41 | 8-K |
| Q4 FY2025 | Mon, Mar 16, 2026 | before open | 75 | 8-K |
| Q3 FY2025 | Mon, Nov 10, 2025 | before open | 41 | 8-K |
| Q2 FY2025 | Mon, Aug 11, 2025 | before open | 42 | 8-K |
| Q1 FY2025 | Mon, May 12, 2025 | before open | 42 | 8-K |
| Q4 FY2024 | Tue, Mar 11, 2025 | before open | 70 | 8-K |
What they guided beta
| Q3 FY2026 | "Based on the current operating plan, the upfront proceeds are expected to support ROBBIN initiation, regulatory activities and operations through the third quarter of 2027." exhibit |
| Q3 FY2026 | "Assuming full exercise of the warrants, the financing is expected to support the planned ROBBIN program and company operations through year-end 2031." exhibit |
| Q3 FY2026 | "Based on the current operating plan, the upfront proceeds are expected to support ROBBIN initiation, regulatory activities and operations through the third quarter of 2027." exhibit |
| Q3 FY2026 | "Assuming full exercise of the warrants, the financing is expected to support the planned ROBBIN program and company operations through year-end 2031." exhibit |
| Q3 FY2026 | "2027: Additional clinical publications and updates as available, and potential additional regulatory submissions About Agenus Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents." exhibit |
| Q2 FY2026 | "ROBBIN addresses approximately 38,000 newly diagnosed U.S. patients annually and an estimated annual U.S. sales opportunity of more than $7 billion; initiation and first patient dosing are expected in the first quarter of 2027" exhibit |
| Q2 FY2026 | "Based on the company’s current operating plan, the upfront proceeds are expected to support ROBBIN initiation, regulatory alignment and company operations through Q3 2027." exhibit |
| Q2 FY2026 | "Assuming full exercise of the warrants, the financing is expected to support the planned ROBBIN program and company operations through year-end 2031." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AGEN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AGEN
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/AGEN/"><img src="https://veritasdata.dev/embed/AGEN.svg" alt="AGEN earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/AGEN/)
Script
<script async src="https://veritasdata.dev/embed/AGEN.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AGEN"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.